The data in the toolkit is drawn from the Institute for Health Economics Comparator Report on Patients Access to Cancer Medicines Revisited - a UK Perspective.
A marketing authorisation works to ensure that when a medicine reaches a patient it works in the same high quality way every time.
A rare disease is officially classified as a condition that affects less than 5 in 10,000 in the general population, but smaller numbers of patients should not mean less focus on treating them.
Every day millions of patients rely on medicines supplied by the pharmaceutical industry.
Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history. Every year, 2 – 3 million lives are saved across the world because of immunisation.
The manufacture and selling of counterfeit medicines is an issue of increasing concern throughout the world. There are potentially fatal consequences for those who inadvertently take such products.
The ABPI and its members are working towards creating a repository of NHS Partnerships case studies, to enable industry to demonstrate what we can achieve in collaboration with the health and care system.
Antimicrobial resistance is a global public health issue requiring multiple solutions and a sustained, coordinated response. The pharmaceutical industry is committed to tackling AMR working alongside governments and NGOs.